Datum: 27.8.2018
Summary:
A Dutch clinical stage company is developing a new generation of nanomedicines. Their aim is to use their nanoparticle technology to improve the efficacy and safety profiles of current and novel drugs for the treatment of solid tumours.
As part of their development strategy, they are looking for a license and/or technical cooperation agreement with academic research labs to exploit their nanoparticles for enhanced tumour targeting of new oligonucleotides with therapeutic potential.
Reference: TRNL20180531001
Country: Netherlands
Submitted: 27. 8. 2018
Keywords
Technology: Clinical Research, Trials, Cytology, Cancerology, Oncology, Medical Research, Pharmaceutical Products / Drugs
Market: Drug delivery and other equipment, Oncology, Pharmaceuticals/fine chemicals
NACE: Research and experimental development on biotechnology, Other human health activities
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnologický portál - Vše o biotechnologiích na jednom místě.
ISSN 1802-2685
Tvorba webových stránek: CREOS CZ
© 2006 - 2024 Jihočeská agentura pro podporu inovačního podnikání o.p.s.
Zajímavé články s biotechnologickým obsahem:
Brigády pro studenty - NabĂdky zajĂmavĂ˝ch brigád pro studenty
DNA - Lidskou DNA má pohltit polárnà led
Živé obvazy s bakteriemi pomáhajà léčit chronické rány
ÄŚĂnštĂ vÄ›dci udÄ›lali z krásnooÄŤka mikrobota ovládanĂ©ho svÄ›tlem